Roles
- Associate Professor
-
Biography
Justin Taylor, M.D. is an Associate Professor in the Division of Hematology at the University of Miami Miller School of Medicine. He completed his residency at Brigham and Women’s Hospital, a fellowship at Memorial Sloan Kettering Cancer Center, and postdoctoral training with Omar Abdel-Wahab, M.D.
Dr. Taylor’s research focuses on recurrent genetic mutations in hematologic malignancies and the development of targeted therapies. His laboratory employs molecular biology, single-cell genomics, and animal models to uncover mechanisms of disease and identify novel therapeutic strategies. His work aims to translate laboratory discoveries into clinical applications to improve outcomes for patients with blood cancers.
He has received multiple research grants and has been recognized with Young Investigator Awards from the American Society of Clinical Oncology (ASCO), the Hairy Cell Leukemia Foundation, and the Evans MDS Foundation. In addition to his research, Dr. Taylor provides clinical care for patients with hematologic malignancies, integrating cutting-edge scientific insights into personalized treatment plans. -
Education & Training
Education
Post Graduate Training
Licensures and Certifications
-
Honors & Awards
-
Research Interests
Dr. Taylor is a physician-scientist devoted to improving outcomes for patients with cancer. He is an Associate Professor and member of the Translational and Clinical Oncology program at the University of Miami Sylvester Comprehensive Cancer Center. The Taylor lab studies the genetics of hematologic malignancies and development of novel therapeutics using animal modeling, molecular biology and single-cell genomic techniques. The focus of the lab is on understanding how genetic alterations in leukemia contribute to oncogenesis or therapeutic resistance. The lab uses molecular biology, genomics, proteomics and mouse modeling to determine the mechanisms and potential targetable weaknesses of these genetic alterations. They also study the potential role for combination targeted therapies. Specifically, they are currently investigating nuclear export and kinase signaling pathways. Dr. Taylor also holds a faculty position in the Department of Medicine, Division of Hematology where he sees patients with hematologic malignancies. -
Publications
Disclaimer: Information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, use this link to inform our data team. Your feedback is appreciated and helps us improve the quality of our content.Professional Activities
Articles & News
What Cancer Drug Resistance Can Teach Researchers About Other Diseases
Sylvester Comprehensive Cancer Center Study Reveals How Blood Cancers Outsmart BTK-Targeted Therapies
How Scientists at Sylvester are Learning to Outrun Cancer Resistance
Disclaimer:
Information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, use this link to inform our data team. Your feedback is appreciated and helps us improve the quality of our content.